Thermo Fisher Scientific TMO · NYSE
$673.27 +1.54% (+$10.23)
Summary
52 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 15 USD is left as net profit.
- It has raised its dividend 8 years in a row and pays out only 9.7% of profit.
What to watch
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 3.5 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 35.7 USD for 1 USD of yearly profit. Over the last five years it was 32.7 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.7% a year over 5 years. Over the last 3 years it fell by 0.3% a year. For the next fiscal year analysts expect revenue to grow by 7.5%. Earnings per share grew by 0.2% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 60 USD
- Research and development 3.0 USD
- Sales and administration 20 USD
- Taxes and other 2.6 USD
- Net profit 15 USD
Net profit, industry median (Medical - Diagnostics & Research) 8.8 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 5.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.27%
- Paid out of profit
- 9.7%
- Raised in a row
- 8 years
You receive $1.84 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 36
- Hold 7
- Sell 0
Today's price within the analysts' price targets
The average target of $631.42 is 6.2% below today's price. 84% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Consumables 42%
- Service 42%
- Instruments 16%
By region
- UNITED STATES 52%
- Europe 27%
- Asia Pacific 18%
- All Other Countries 3.6%
Consumables brings in 42% of revenue. Service grew fastest, by 20% a year.
Segments in detail